Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Summary

The primary objective of this study is: * assess the safety and tolerability of ecallantide in paediatric patients for acute attacks of HAE The secondary objectives are: * evaluate the pharmacokinetic profile of ecallantide in paediatric patients treated for acute attacks of HAE * assess the efficacy of ecallantide in paediatric patients treated for moderate to severe acute attacks of HAE

Timeline

Start

2012-06-01

Primary completion

2015-04-01

Completion

—

Drugs

Indications